Estrigenix Therapeutics, Inc. presents at American Chemical Society’s Midwest Regional Meeting
MILWAUKEE (Oct. 19, 2022) – Estrigenix Therapeutics, Inc., a Wisconsin-based, privately held pharmaceutical company leading the way in estrogen biology, is presenting atthe Midwest Regional Meeting of the American Chemical Society in Iowa City, Iowa on Wednesday, October 19, 2022. William Donaldson, Ph.D., chief executive officer (CEO) of Estrigenix is presenting an abstract entitled, “Discovery … Estrigenix Therapeutics, Inc. presents at American Chemical Society’s Midwest Regional Meeting